UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. 1)*
LifeStance Health Group, Inc.
(Name of Issuer)
Common stock, par value $0.01 per share
(Title of Class of Securities)
53228F101
(CUSIP Number)
December 31, 2022
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
| ☐ | Rule 13d-1(b) |
| ☐ | Rule 13d-1(c) |
| ☒ | Rule 13d-1(d) |
| * | The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. |
The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
| 1. | Names of Reporting Persons
Michael K. Lester | |||||
| 2. | Check the Appropriate Box if a Member of a Group (See Instructions) (a) ☐ (b) ☐
| |||||
| 3. | SEC Use Only
| |||||
| 4. | Citizenship or Place of Organization
United States | |||||
Number of Shares Beneficially Owned by Each Reporting Person With | 5. | Sole Voting Power
19,993,012 | ||||
| 6. | Shared Voting Power
0 | |||||
| 7. | Sole Dispositive Power
19,993,012 | |||||
| 8. | Shared Dispositive Power
0 | |||||
| 9. | Aggregate Amount Beneficially Owned by Each Reporting Person
19,993,012 | |||||
| 10. | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)
☐ | |||||
| 11. | Percent of Class Represented by Amount in Row (9)
5.3% (1) | |||||
| 12. | Type of Reporting Person (See Instructions)
IN | |||||
| 1 | Calculated based on 375,986,406 shares of common stock, par value $0.01 per share outstanding as of November 1, 2022 as reported on the Issuer’s 10-Q, filed on November 9, 2022. |
SCHEDULE 13G
Item 1.
| (a) | Name of Issuer |
LifeStance Health Group, Inc., Delaware corporation (the “Issuer”)
| (b) | Address of Issuer’s Principal Executive Offices |
4800 N. Scottsdale Road, Suite 6000, Scottsdale, Arizona 85251
Item 2.
| (a) | Name of Person Filing |
This Schedule 13G is being filed on behalf of Michael K. Lester
| (b) | Address of Principal Business Office or, if none, Residence |
The address of the principal business office of the Reporting Person is 4800 N. Scottsdale Road, Suite 6000, Scottsdale, Arizona 85251.
| (c) | Citizenship |
United States
| (d) | Title of Class of Securities |
Common stock, par value $0.01 per share (the “Common Stock”)
| (e) | CUSIP Number |
53228F101
| Item 3. | If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: |
This Item 3 is not applicable.
| Item 4. | Ownership |
| (a) | Amount beneficially owned: |
As of the date hereof, the Reporting Person beneficially owns 19,993,012 shares of Common Stock, representing approximately 5.3% of the outstanding shares of Common Stock.
The percentage of the outstanding shares of Common Stock held by the Reporting Person is based on 375,986,406 shares of Common Stock issued and outstanding as of November 1, 2022 as reported on the Issuer’s 10-Q, filed on November 9, 2022.
| (b) | Percent of class: |
See Item 4(a) hereof.
| (c) | Number of shares as to which the person has: |
| Item 5. | Ownership of Five Percent or Less of a Class |
This Item 5 is not applicable.
| Item 6. | Ownership of More than Five Percent on Behalf of Another Person |
None.
| Item 7. | Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person |
This Item 7 is not applicable.
| Item 8. | Identification and Classification of Members of the Group |
This Item 8 is not applicable.
| Item 9. | Notice of Dissolution of Group |
This Item 9 is not applicable.
| Item 10. | Certification |
This Item 10 is not applicable.
Signature
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Date: February 13, 2023
| By: | /s/ Michael Lester | |
| Name: Michael Lester |
